About ePlus Cancer Care
ePlus Cancer Care is a company based in Nashville (United States) founded in 2002 was acquired by ION in June 2019. ePlus Cancer Care offers products and services including Oncology Network Platform and Growth Strategy Services. ePlus Cancer Care operates in a competitive market with competitors including City of Hope, Fred Hutch, Moffitt Cancer Center, Maryland Oncology Hematology and Cancer Specialists, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Alliance HealthCare Services
& 3 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ePlus Cancer Care
ePlus Cancer Care offers a comprehensive portfolio of products and services, including Oncology Network Platform and Growth Strategy Services.
Platform for operational support and analytics in oncology practices
Services aiding physician growth and market dynamics in healthcare
Funding Insights of ePlus Cancer Care
Investors in ePlus Cancer Care
ePlus Cancer Care has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Alliance HealthCare Services, Kohlberg & Company and Frontenac.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on buyouts
|
Locked | Locked | Locked | |
|
Frontenac is engaged in private equity investments for middle-market companies.
|
Locked | Locked | Locked | |
|
Outsourced radiology, interventional, and oncology services are provided nationally.
|
Locked | Locked | Locked |
Investor details for ePlus Cancer Care
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ePlus Cancer Care
Investment portfolio details for ePlus Cancer Care
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ePlus Cancer Care
Detailed financials for ePlus Cancer Care
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eplus Cancer Care Comparisons
Peer comparison for ePlus Cancer Care
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ePlus Cancer Care
ePlus Cancer Care operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as City of Hope, Fred Hutch, Moffitt Cancer Center, Maryland Oncology Hematology and Cancer Specialists, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of oncology clinics
|
|
| Locked | Locked | Locked |
Life-threatening diseases are addressed through diagnostic research efforts.
|
|
| Locked | Locked | Locked |
Oncology care is delivered via a network of specialized clinics.
|
|
| Locked | Locked | Locked |
Offers oncology treatments, hematology services, and access to clinical trials.
|
|
| Locked | Locked | Locked |
Offers cancer care through oncology, diagnostics, and patient support in North Florida.
|
Detailed competitors of ePlus Cancer Care
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eplus Cancer Care
Complete news archive for ePlus Cancer Care
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ePlus Cancer Care
ePlus Cancer Care was founded in 2002 and raised its 1st funding round 9 years after it was founded.
ePlus Cancer Care is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Tom Weiss is the current CEO of ePlus Cancer Care.
ePlus Cancer Care was founded in 2002 and is headquartered in Nashville, United States. Oncology services are provided through a network of clinics focused on cancer care. Operations encompass diagnosis, treatment, and support in the healthcare sector. The company serves patients across multiple locations, emphasizing specialized medical interventions for oncology needs.
ePlus Cancer Care's top competitors include City of Hope, Moffitt Cancer Center and Fred Hutch.
ePlus Cancer Care offers Oncology Network Platform and Growth Strategy Services.
ePlus Cancer Care has 4 investors. Key investors include Alliance HealthCare Services, Kohlberg & Company, Frontenac, and ION.